BMPR2 and fetal growth restriction: IUGR may block the proliferative Bmpr1a/Bmpr2 pathways during the intrauterine phase, while it is shifted to pro-proliferative signaling by postnatal reduction of Bmpr1b as an attempt to promote vascularisation and compensate for the intrauterine growth restriction32.